Myrti'lla®
-
- Bilberry (Vaccinium myrtillus) leaf extract
- Made from organic bilberry leaves carefully sourced from certified organic farms in Europe, Myrti’lla® is an active ingredient naturally containing polyphenols, especially chlorogenic acids, with rapid efficacy on skin microcirculation. It stimulates the formation of new vessels, reinforcing the capillary network and improving blood flow. This enhanced microcirculation promotes better oxygenation and nutrient delivery to the skin, helps reduce redness, and contributes to a fresher, more uniform complexion. Its targeted action makes it particularly suitable for formulations addressing sensitive skin and redness-prone concerns.
- Ingredient
- Sourcing
- Science
- Recommended dose, claims & application
Ingredient
INCI
Vaccinium myrtillus leaf extract
Composition
- Total polyphenols (Folin-Ciocalteu) ≥ 12%
- Total chlorogenic acids ≥ 7%
Description
Extracted from organic bilberry leaves, the active ingredient Myrti’lla® improves skin microcirculation and reduces redness quickly and effectively. This oxygenates and nourishes the skin, resulting in a fresh, redness-free complexion. This makes the ingredient ideal for formulations that address sensitive and redness-prone skin.
Dosage form or appearance
Beige powder extract
Sourcing
Organic bilberry leaves are sourced from certified organic farms and wild harvest areas in Europe with fertile soils and a temperate climate that supports the natural growth of Vaccinium myrtillus (European blueberry). Local growers and collectors follow sustainable and organic agricultural practices, emphasizing biodiversity, soil health, and minimal environmental impact.
Harvesting is done by hand, ensuring careful selection and preservation of the leaves’ botanical quality. The sourcing process benefits from deep-rooted local expertise and longstanding traditions of wild plant collection, combined with modern organic certification that guarantees purity and traceability. This approach ensures a high-quality, authentic natural ingredient, ideal for use in cosmetic formulations requiring organic and responsibly sourced botanicals.
Science
Proprietary preclinical studies
-Improvement of microcirculation (in vitro):
An in vitro study was conducted on Human microvascular endothelial cells treated with Myrti’lla® in order to evaluate the pseudo-tube formation using an angiogenesis test. After 3 hours of incubation, cell differentiation leading to the formation of pseudo-tubes was evaluated using an inverted microscope. Image acquisition revealed that Myrti’lla® improves microcirculation by stimulating the formation of new blood vessels.
Clinical study
-Evaluation of the anti-redness effect:
A trial evaluating the anti-redness effect of Myrti’lla® was carried out on 17 women with reactive skin and facial rosacea. The women applied a cream containing 0.5% Myrti’lla® to one side of their face and a placebo to the other side, twice daily for 28 days. Following a clinical assessment of the skin and measurement of haemoglobin levels in the epidermis and dermis using a non-invasive method, the results showed that Myrti’lla® produced an immediate anti-redness effect 30 minutes after application and long term effect after 28 days.
Recommended dose, claims & application
Recommended dose
- 0.5%
- Incorporation in oily phase
Claims
- Immediate and long term effect to reduce redness
- Improves microcirculation by stimulating the formation of new vessels
Application
- Anti-redness creams
- Care products for sensitive skin
- Anti-aging care
- Eye contour care
Related products
To obtain the safety data sheet or any other technical information about the product